Effects of Social Media Use on Young Adults' E-Cigarette Use

February 19, 2024 updated by: University of Oklahoma

Identifying and Addressing the Effects of Social Media Use on Young Adults' E-Cigarette Use: A Solutions-Oriented Approach

The goal of this clinical trial is to test the effects of social media use on e-cigarette use in young adults who use e-cigarettes. The main questions it aims to answer are:

  • Does reducing social media use change young adults' e-cigarette use?
  • Does reducing social media use change things such as young adults' mental health and what they see on social media?

Participants will complete surveys and submit screenshots showing how much time they spend on social media.

Researchers will compare young adults who reduce their social media use to young adults who use social media as usual, to see if their e-cigarette use differs.

Study Overview

Status

Recruiting

Detailed Description

The overall goals of this project are to understand how young adults' social media use affects their nicotine vaping and to identify intervention targets that mitigate social media's impact on vaping. Prevalence of vaping and social media use among young adults have increased in tandem. Exposure to vaping-related social media content is common and is associated with vaping. Intense social media use appears to contribute to young adults' increased mental health symptoms, which are linked to tobacco product use. This project aims to contribute to scientific understanding of the causal links between social media use and vaping in young adulthood. Young adults with past-month vaping will report time spent on social media, vaping-related social media content exposure, social comparison on social media, mental health, and vaping behavior. After a 1-month baseline measurement period, they will be randomized to reduce their social media use (incentivized) or use social media as usual for a 3-month experimental period. Longitudinal within- and between-subjects analyses will test relationships between time spent on social media, risk factors for vaping, and vaping behavior. Specific research aims are to: (1) investigate the relationships between a reduction in social media use and: a) vaping content exposure, b) social comparison, and c) mental health, and (2) examine whether reducing social media use reduces past-month vaping days, vaping episodes per vaping day, and puffs per vaping episode.

Study Type

Interventional

Enrollment (Estimated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Oklahoma
      • Oklahoma City, Oklahoma, United States, 73104
        • Recruiting
        • University of Oklahoma Health Sciences Center
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age 18-25
  • Daily social media use
  • Ownership of a smartphone
  • Vaping (i.e., use of a nicotine e-cigarette) on 1-19 days of the past 30 days
  • Residing in the United States

Exclusion Criteria:

-Lack of capacity to provide informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Social Media Use Reduction
Participants will be incentivized to reduce their social media use by a pre-specified percentage from baseline.
No Intervention: Social Media Use as Usual

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Past-month vaping days
Time Frame: Collected at baseline, 1mo, 3mo, 6mo
Number of days the participant vaped nicotine in the past 30 days
Collected at baseline, 1mo, 3mo, 6mo

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Episodes per vaping day
Time Frame: Collected at baseline, 1mo, 3mo, 6mo
Average number of times the participant used a nicotine vaping device on each day (of the past 30) they vaped nicotine
Collected at baseline, 1mo, 3mo, 6mo
Puffs per vaping episode
Time Frame: Collected at baseline, 1mo, 3mo, 6mo
Past-month number of puffs per nicotine vaping episode (1-20)
Collected at baseline, 1mo, 3mo, 6mo

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Erin A Vogel, PhD, University of Oklahoma

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 4, 2023

Primary Completion (Estimated)

April 1, 2024

Study Completion (Estimated)

April 1, 2024

Study Registration Dates

First Submitted

November 15, 2023

First Submitted That Met QC Criteria

November 15, 2023

First Posted (Actual)

November 22, 2023

Study Record Updates

Last Update Posted (Actual)

February 20, 2024

Last Update Submitted That Met QC Criteria

February 19, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 15427
  • K01DA055073 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Deidentified data will be available from the Principal Investigator upon reasonable request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Electronic Cigarette Use

Clinical Trials on Social Media Use Reduction

3
Subscribe